beta-(6,8-Dibromo-2-methyl-3,4-dihydro-4-oxoquinazolin-3-yl)ethyl diphenylacetate
Molecular Formula:
C25H21Br2N3O3
InChI: InChI=1/C25H21Br2N3O3/c1-17-28-24-21(14-18(26)15-22(24)27)25(32)29(17)12-13-33-23(31)16-30(19-8-4-2-5-9-19)20-10-6-3-7-11-20/h2-11,14-15H,12-13,16H2,1H3
InChIKey: InChIKey=KPQDTRDYPWFYNE-UHFFFAOYAZ
SMILES: CC1=NC2=C(C=C(C=C2C(=O)N1CCOC(=O)CN(C3=CC=CC=C3)C4=CC=CC=C4)Br)Br
Names:
beta-(6,8-Dibromo-2-methyl-3,4-dihydro-4-oxoquinazolin-3-yl)ethyl diphenylacetate
Glycine, N,N-diphenyl-, 2-(6,8-dibromo-2-methyl-4-oxo-3(4H)-quinazolinyl)ethyl ester
GLYCINE, N,N-DIPHENYL-, 2-(6,8-DIBROMO-2-METHYL-4-OXO-3(4H)-QUINAZOLINYL)ETHYL E
N,N-Diphenylglycine 2-(6,8-dibromo-2-methyl-4-oxo-3(4H)-quinazolinyl)ethyl ester
110009-10-4
2-(6,8-dibromo-2-methyl-4-oxo-quinazolin-3-yl)ethyl 2-(diphenylamino)acetate
Registries:
PubChem CID 60390
PubChem ID 196705
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|